Genetic Testing

Applied DNA Launches Mpox Clade I and Clade II  Testing ServiceApplied DNA Launches Mpox Clade I and Clade II  Testing Service

Applied DNA Launches Mpox Clade I and Clade II Testing Service

STONY BROOK, NY / ACCESSWIRE / September 11, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in…

8 months ago
Genetic Technologies Invited to Join Prestigious “CancerIQ” Online Platform – Provides Access to 45 Healthcare Systems and 250 ClinicsGenetic Technologies Invited to Join Prestigious “CancerIQ” Online Platform – Provides Access to 45 Healthcare Systems and 250 Clinics

Genetic Technologies Invited to Join Prestigious “CancerIQ” Online Platform – Provides Access to 45 Healthcare Systems and 250 Clinics

MELBOURNE, Australia, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader…

8 months ago
Tay-Sachs Awareness Month: Prioritize Your Health With JscreenTay-Sachs Awareness Month: Prioritize Your Health With Jscreen

Tay-Sachs Awareness Month: Prioritize Your Health With Jscreen

ATLANTA, GA / ACCESSWIRE / September 9, 2024 / Shari Ungerleider and Myra Sack have one thing in common: they…

8 months ago
Sequentify and Dexter Collaborate to Introduce Genomic Sequencing Solutions to the Romanian MarketSequentify and Dexter Collaborate to Introduce Genomic Sequencing Solutions to the Romanian Market

Sequentify and Dexter Collaborate to Introduce Genomic Sequencing Solutions to the Romanian Market

REHOVOT, Israel, Sept. 5, 2024 /PRNewswire/ -- Sequentify has partnered with Dexter, a Romanian distributor, to bring Sequentify's InfiniSeq™ library…

8 months ago
Myriad Genetics to Host Investor Event on October 9, 2024Myriad Genetics to Host Investor Event on October 9, 2024

Myriad Genetics to Host Investor Event on October 9, 2024

SALT LAKE CITY, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and…

8 months ago
Constantiam Biosciences Secures $2.05M Phase II SBIR Grant from NHGRI to Advance Functional Analysis Platform for Variants of Uncertain Significance (VUS)Constantiam Biosciences Secures $2.05M Phase II SBIR Grant from NHGRI to Advance Functional Analysis Platform for Variants of Uncertain Significance (VUS)

Constantiam Biosciences Secures $2.05M Phase II SBIR Grant from NHGRI to Advance Functional Analysis Platform for Variants of Uncertain Significance (VUS)

HOUSTON, Sept. 4, 2024 /PRNewswire/ -- Constantiam Biosciences, a startup focused on powering genomic medicine, is pleased to announce that…

8 months ago
Rhythm Pharmaceuticals to Present at Wells Fargo Healthcare Conference in SeptemberRhythm Pharmaceuticals to Present at Wells Fargo Healthcare Conference in September

Rhythm Pharmaceuticals to Present at Wells Fargo Healthcare Conference in September

BOSTON, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the…

8 months ago
Applied DNA Submits Validation Package to New York State Department of Health to Expand Linea Mpox Virus 1.0 Assay to Mpox Clade IApplied DNA Submits Validation Package to New York State Department of Health to Expand Linea Mpox Virus 1.0 Assay to Mpox Clade I

Applied DNA Submits Validation Package to New York State Department of Health to Expand Linea Mpox Virus 1.0 Assay to Mpox Clade I

-Validation Studies Confirmed the Assay Can Detect Mpox Clade I and Clade Ib in addition to Clade II- STONY BROOK,…

9 months ago